3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
8
Fallopian Tube Neoplasms
6
Breast Neoplasms
5
Sarcoma
3
Ovarian Cancer Recurrent
3
Carcinoma, Ovarian Epithelial
3
Sarcoma, Ewing
2
Neoplasm Metastasis
2
Leiomyosarcoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrence
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Low Grade Serous Ovarian Cancer
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HER2-negative Breast Cancer
1
Gliosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Dermatofibrosarcoma
1
Interventions
pembrolizumab
25
Paclitaxel
20
Carboplatin
17
Bevacizumab
12
Specimen Handling
10
Letrozole
10
abemaciclib
7
dostarlimab
6
Taxes
6
Blood Specimen Collection
6
Medroxyprogesterone Acetate
5
Magnetic Resonance Spectroscopy
5
Fulvestrant
5
Drug Therapy
5
Doxorubicin
5
Cisplatin
5
Biopsy
5
olaparib
4
lenvatinib
4
atezolizumab
4
Radiotherapy
4
Progestins
4
Observation
4
Nivolumab
4
Megestrol Acetate
4
Immunoglobulin G
4
Gemcitabine
4
trastuzumab deruxtecan
3
palbociclib
3
X-Rays
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Endometrial Neoplasms
×
liposomal doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled